COTRIM D.S Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cotrim D.s, and when can generic versions of Cotrim D.s launch?
Cotrim D.s is a drug marketed by Teva and is included in one NDA.
The generic ingredient in COTRIM D.S is sulfamethoxazole; trimethoprim. There are twenty-seven drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the sulfamethoxazole; trimethoprim profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cotrim D.s
A generic version of COTRIM D.S was approved as sulfamethoxazole; trimethoprim by SUN PHARM INDUSTRIES on August 25th, 1986.
Summary for COTRIM D.S
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | COTRIM D.S at DailyMed |
US Patents and Regulatory Information for COTRIM D.S
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva | COTRIM D.S. | sulfamethoxazole; trimethoprim | TABLET;ORAL | 070048-001 | Mar 18, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |